| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/21/2005 | WO2005034994A1 Remedy for solid tumor |
| 04/21/2005 | WO2005034979A2 Methods and compositions for enhancing innate immunity and antibody dependent cellular cytotoxicity |
| 04/21/2005 | WO2005034737A2 Methods for diagnosing and treating endoplasmic reticulum (er) stress diseases |
| 04/21/2005 | WO2005034733A2 Methods and compositions for diagnosis and treatment of b cell chronic lymphocytic leukemia |
| 04/21/2005 | WO2005016970A3 Fully human antibodies directed against the human insulin-like growth factor-1 receptor |
| 04/21/2005 | WO2005016969A3 Cd20-binding polypeptide compositions |
| 04/21/2005 | WO2005016968A3 Reducing protein a leaching during protein a affinity chromatography |
| 04/21/2005 | WO2005011721A3 Use of a pak inhibitor for the treatment of a joint disease |
| 04/21/2005 | WO2004109286A3 Methods for detecting and treating cancer using podocalyxin and/or endoglycan |
| 04/21/2005 | WO2004108888A3 Micropositioning cells for tissue engineering |
| 04/21/2005 | WO2004090110A3 Compositions and methods for the control, differentiation and/or manipulation of pluripotent cells through a gamma-secretase signaling pathway |
| 04/21/2005 | WO2004087746A3 Staphylococcus epidermidis antigens |
| 04/21/2005 | WO2004083388A3 Polynucleotide encoding a novel human g-protein coupled receptor variant of hm74, hgprbmy74 |
| 04/21/2005 | WO2004078942A3 Endothelial cell specific antibodies and uses thereof |
| 04/21/2005 | WO2004071462A3 Methods and compositions for treatment of viral infections based on tsg101-vps28 interaction |
| 04/21/2005 | WO2004066937A3 Antibodies specific for plasmacytoid dendritic cells |
| 04/21/2005 | WO2004031400A3 Amyloid beta-derived diffusible ligands (addls), addl-surrogates, addl-binding molecules, and uses thereof |
| 04/21/2005 | WO2004020588A3 Transferrin fusion protein libraries |
| 04/21/2005 | WO2003106639A3 Recombination of nucleic acid library members |
| 04/21/2005 | WO2003049673A3 Methods and compositions for control of bone formation via modulation of sympathetic tone |
| 04/21/2005 | WO2003048349A8 Acetoacetyl-coa thiolase and use of for the identification of novel fungicidal substances |
| 04/21/2005 | WO2002092842A3 Nucleic acids and corresponsing proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer |
| 04/21/2005 | WO2002092841A3 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon |
| 04/21/2005 | US20050086711 Transgenic animals and methods for screening for anti-amyloidogenic agents and agents for treating neurodegenerative disease |
| 04/21/2005 | US20050086707 Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer |
| 04/21/2005 | US20050085628 Centromere specific monoclonal antibody for use in detection or identification of chromosomal aberrations, and in elucidation of the structure or the mechanism of centromere |
| 04/21/2005 | US20050085627 Nucleotide sequences coding histone methyltransferase for use in identifying modulators for treatment and prevention of asthma disorders |
| 04/21/2005 | US20050085556 Generated by atherosclerosis plaque; contacting with antibody; measurement; calibration |
| 04/21/2005 | US20050085419 Anti-growth factor receptor avidin fusion proteins as universal vectors for drug delivery |
| 04/21/2005 | US20050085175 Method and compositions for processing poultry feathers |
| 04/21/2005 | US20050084936 Human regulatory proteins |
| 04/21/2005 | US20050084913 Tumor antigen for use as tool in diagnosis, prevention and treatment of cell proliferative disorders; immunotherapy |
| 04/21/2005 | US20050084910 Using Fc epsilon RII receptor concentration as diagnostic indicator of food allergies, parasitic infection and inflammatory bowel disease |
| 04/21/2005 | US20050084897 DNA encoding human vanilloid receptor VR3 |
| 04/21/2005 | US20050084877 Expression vector comprising nucleotide sequences coding hydrolase for as tool in detecting modulators of enzymatic activity; enzyme inhibitors; drug screening |
| 04/21/2005 | US20050084873 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 04/21/2005 | US20050084860 Inhibition of tristetraproline for protection of the heart from cardiac injuries |
| 04/21/2005 | US20050084859 Herbicide metabolizing proteins; ferredoxins; methylation, dehydrogenation; kits |
| 04/21/2005 | US20050084857 Breast tumor antigen for use as tool in diagnosis prevention and treatment of mammary gland cell proliferative disorders; antitumor agents |
| 04/21/2005 | US20050084850 Stromal cell protein for use as tool in stimulating blood production in patients undergoing chemotherapy |
| 04/21/2005 | US20050084846 Using mucin-1 expression after exposure to interferon as prognostic tool in predicting respiratory infection |
| 04/21/2005 | US20050084845 Immunoglobulin specific to hepatitis c viral envelope protein for use as tool prevention and treatment of viral diseases |
| 04/21/2005 | US20050084502 Equine herpesvirus vaccine |
| 04/21/2005 | US20050084495 Altering A B cell pathology using self-derived antigens in conjunction with specific-binding cytoreductive agent |
| 04/21/2005 | US20050084493 Drug screening for antibodies capable of binding to the Interleukin-1 (IL-1) receptor without activating it; involves phage display, surface plasmon resonance; potential use treating rheumatoid arthritis and other IL-1 mediated diseases |
| 04/21/2005 | US20050084492 Assay method to monitor the response of anti-cytokine therapy |
| 04/21/2005 | US20050084491 Use as an immunogen to generate anti-integrin antibodies; a mimotope; vaccinating against angiogenic and metastatic diseases |
| 04/21/2005 | US20050084489 Synergistic administration of Vitaxin, a FAB fragment, or a competitive binding antibody for binding integrin alpha V beta 3 with the enzyme inhibitor; antiinflammatory, anticarcinogenic agents; autoimmune and metabolic bone disorders |
| 04/21/2005 | US20050084487 Bone disorders, antiarthritic agents; immunizing transgenic knockout animals to obtain anti-WIF-1 antibodies |
| 04/21/2005 | US20050084449 Antibodies against T cell immunoglobulin domain and mucin domain 1 (TIM-1) antigen and uses thereof |
| 04/21/2005 | CA2761987A1 Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer |
| 04/21/2005 | CA2548787A1 Antibody composition specifically binding to ganglioside gm2 |
| 04/21/2005 | CA2546730A1 A method for the treatment of malignant diseases by inhibiting nucleolin |
| 04/21/2005 | CA2542608A1 Igf-i responsive gene and use thereof |
| 04/21/2005 | CA2542130A1 Cell genomically modified to produce polypeptides with an altered glycosylation pattern |
| 04/21/2005 | CA2542125A1 Process for producing antibody composition by using rna inhibiting the function of .alpha.1,6-fucosyltransferase |
| 04/21/2005 | CA2542099A1 Methods and compositions for enhancing innate immunity and antibody dependent cellular cytotoxicity |
| 04/21/2005 | CA2542046A1 Fused protein composition |
| 04/21/2005 | CA2542044A1 Fully human antibodies against human 4-1bb (cd137) |
| 04/21/2005 | CA2542042A1 Antibody composition specifically binding to il-5 receptor |
| 04/21/2005 | CA2542037A1 Composition of antibody capable of specifically binding ccr4 |
| 04/21/2005 | CA2541804A1 Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer |
| 04/21/2005 | CA2541671A1 Bispecific antibody substituting for functional proteins |
| 04/21/2005 | CA2541464A1 Piscirickettsia salmonis antigens and use thereof |
| 04/21/2005 | CA2541438A1 The modulation of hyaluronan synthesis and degradation in the treatment of disease |
| 04/21/2005 | CA2541360A1 Methods and compositions for diagnosis and treatment of b cell chronic lymphocytic leukemia |
| 04/21/2005 | CA2540165A1 Native immunoglobulin binding reagents and methods for making and using same |
| 04/21/2005 | CA2539999A1 Antibody compositions and methods |
| 04/21/2005 | CA2539681A1 Nucleic acid molecules encoding novel human low-voltage activated calcium channel proteins, designated - alpha 1i-1 and alpha 1i-2, encoded proteins and methods of use thereof |
| 04/21/2005 | CA2537473A1 Cytokine involved in epithelial-mesenchymal transition |
| 04/21/2005 | CA2537055A1 Humanization of antibodies |
| 04/20/2005 | EP1524275A2 Deimmunized binding molecules to CD3 |
| 04/20/2005 | EP1523571A2 Sgk and nedd used as diagnostic and therapeutic targets |
| 04/20/2005 | EP1523503A1 Therapeutic antibodies with reduced side effects |
| 04/20/2005 | EP1523499A2 Fragments of beta-amyloid as targets for vaccination against alzheimer disease |
| 04/20/2005 | EP1523496A2 Recombinant production of mixtures of antibodies |
| 04/20/2005 | EP1523322A2 Novel proteins and nucleic acids encoding same |
| 04/20/2005 | EP1523308A2 Phenylthiocarbamide (ptc) taste receptor |
| 04/20/2005 | EP1185649B1 The myostatin gene promoter and inhibition of activation thereof |
| 04/20/2005 | EP1141326B1 Human akt-3 |
| 04/20/2005 | EP1113817B1 Process and materials for the rapid detection of streptococcus pneumoniae employing purified antigen-specific antibodies |
| 04/20/2005 | EP1068226B1 Lipopeptides inducing t lymphocytic cytotoxicity bearing at least one auxiliary t epitope, and uses for vaccination |
| 04/20/2005 | EP1009753B1 Hypoxia-regulated genes |
| 04/20/2005 | EP0917471B1 Treatment and diagnosis of infections of gram positive cocci |
| 04/20/2005 | EP0871704B1 Transcriptional co-repressor that interacts with nuclear hormone receptors and uses therefor |
| 04/20/2005 | EP0835301B1 Monoclonal antibody directed against rat beta 2 integrin alpha d subunit and corresponding hybridoma |
| 04/20/2005 | EP0805859B1 A chemokine receptor able to bind to mcp-1, mip-1 alpha and/or rantes. its uses |
| 04/20/2005 | EP0700430B1 Methods for selectively stimulating proliferation of t cells |
| 04/20/2005 | CN1607961A Remedies for arthritis |
| 04/20/2005 | CN1607960A Glycoprotein compositions |
| 04/20/2005 | CN1607959A Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells |
| 04/20/2005 | CN1607006A Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
| 04/20/2005 | CN1607005A Soluble lymphotoxin- beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease |
| 04/19/2005 | US6881833 Component in the hedgehog signalling pathway |
| 04/19/2005 | US6881823 Comprises nucleotide sequences coding secreted polypeptides for diagnosing, preventing |
| 04/19/2005 | US6881822 Antibody for use in the treatment of tumors |
| 04/19/2005 | US6881821 Hepatitis-C virus type 4, 5, and 6 |
| 04/19/2005 | US6881574 Noninvasive detection of colorectal cancer and other gastrointestinal pathology |
| 04/19/2005 | US6881573 Augmented solvent/detergent method for inactivating enveloped and non-enveloped viruses |
| 04/19/2005 | US6881564 Enzymatic peptide comprising modified asparaginic residues for treatment of tumors, infection, liver and autoimmune disorders |